Forms of dacryocystitis include acute, chronic, acquired, and congenital dacryocystitis.
Acute dacryocystitis is a sudden infection or inflammation of the tear sac, with an abrupt onset of symptoms, such as eye pain, redness, and swelling. Acute dacryocystitis is often caused by a bacterial infection.
Chronic dacryocystitis is an infection or inflammation of the tear sac that occurs gradually over time and persists for a long period of time. A common cause includes chronic nasolacrimal duct obstruction, which may be due to repeated infection; chronic inflammatory debris in the lacrimal system; dacryoliths, or stones, that form in the inner part of the tear duct. Autoimmune diseases, such as Wegener’s granulomatosis, sarcoidosis, and systemic lupus erythematosus (SLE) can predispose to chronic dacryocystitis.
Acquired dacryocystitis typically results from repeated trauma; surgeries; medications; and neoplasms, or abnormal masses of tissue. The most common traumas resulting in nasolacrimal duct obstruction are nasoethmoid fractures, caused by high-impact anterior force to the nose. Endonasal and endoscopic sinus procedures can very rarely cause damage to the lacrimal sac. Ophthalmic medications commonly associated with acquired dacryocystitis are timolol, pilocarpine, dorzolamide, idoxuridine, and trifluridine. Oral medications that are commonly associated with acquired dacryocystitis are fluorouracil and docetaxel. The most commonly associated neoplasms include lacrimal sac tumors and benign papillomas, or overgrowth of epithelial tissue.
Congenital dacryocystitis is typically due to membranous obstruction in the distal nasolacrimal duct. Prior to birth, the nasolacrimal system is filled with amniotic fluid, and if the amniotic fluid fails to drain from the nasolacrimal system, it can become infected within a few days, resulting in dacryocystitis.